EW Healthcare Partners, L.P.'s Net Worth

$243 Million

Estimate Recalculated Sep 17, 2024 08:17PM EST

Who is EW Healthcare Partners, L.P.

EW Healthcare Partners, L.P. has an estimated net worth of $243 Million. This is based on reported shares across multiple companies, which include EyePoint Pharmaceuticals, Inc., Axogen, Inc., and Venus Concept Inc..

SEC CIK

EW Healthcare Partners, L.P.'s CIK is 0001612343

Past Insider Trading and Trends

2019 was EW Healthcare Partners, L.P.'s most active year for acquiring shares with 5 total transactions. EW Healthcare Partners, L.P.'s most active month to acquire stocks was the month of October. 2017 was EW Healthcare Partners, L.P.'s most active year for disposing of shares, totalling 1 transactions. EW Healthcare Partners, L.P.'s most active month to dispose stocks was the month of May. 2018 saw EW Healthcare Partners, L.P. paying a total of $50,116,716.76 for 40,697,105 shares, this is the most they've acquired in one year. In 2017 EW Healthcare Partners, L.P. cashed out on 1,150,000 shares for a total of $22,701,000.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EyePoint Pharmaceuticals, Inc.

Investor
Updated Sep 06, 2023
Form 4/A
-0.57%
-20.00K
$9.90
-$197.98K
Sep 06, 2023
3.49M
Sale
Sep 01
Form 4
-0.57%
-20.00K
$9.90
-$197.98K
Sep 06, 2023
3.49M
Sale
Sep 01
Form 4
-3.82%
-139.47K
$10.54
-$1.47M
Sep 01, 2023
3.51M
Sale
Aug 30 - Aug 31
Form 4
-3.91%
-148.71K
$11.14
-$1.66M
Aug 30, 2023
3.65M
Sale
Aug 28 - Aug 29
Form 4/A
-5.57%
-223.94K
$11.11
-$2.49M
Aug 30, 2023
3.80M
Sale
Aug 24 - Aug 25
Form 4
-5.57%
-223.94K
$13.25
-$2.97M
Aug 28, 2023
3.80M
Sale
Aug 24 - Aug 25
Form 4
-4.01%
-167.88K
$13.49
-$2.26M
Aug 24, 2023
4.02M
Sale
Aug 22 - Aug 23
Form 4
66.21%
33.73M
$1.27
$42.67M
Jul 03, 2018
84.67M
Purchase
Jun 25
Form 4
100.00%
8.61M
$1.10
$9.47M
Apr 02, 2018
17.21M
Purchase
Mar 28
Form 3
Apr 02, 2018
8.61M
Showing 10 results

Axogen, Inc.

Investor
Updated Nov 21, 2017
Form 4
-23.66%
-1.15M
$19.74
-$22.70M
Nov 21, 2017
3.71M
Sale
Nov 20
Form 3
Sep 02, 2015
4.86M
Showing 2 results

Venus Concept Inc.

Investor
Updated Jan 19, 2024
Form 4
1.60M
Jan 19, 2024
Purchase
Jan 18
Form 4
46.82%
502.51K
$3.98
$2.00M
Oct 20, 2023
1.58M
Purchase
Oct 20
Form 4
37.44%
292.40K
$3.42
$1.00M
Sep 12, 2023
1.07M
Purchase
Sep 08
Form 4
178.00%
500.00K
Jul 13, 2023
780.90K
Purchase
Jul 12
Form 4
280.90K
$7.12
$2.00M
May 17, 2023
280.90K
Purchase
May 15
Form 4/A
1.50M
$2.00
$3.00M
Nov 22, 2022
1.50M
Purchase
Nov 18
Form 4
1.50M
$2.00
$3.00M
Nov 22, 2022
1.50M
Purchase
Nov 18
Form 4
13.94%
3.92M
$1.25
$4.90M
Dec 17, 2021
32.04M
Purchase
Dec 15
Form 4
24.59%
4.86M
Jun 18, 2020
24.63M
Options
Jun 16
Form 4
4.59M
$25.00
$13.50M
Mar 20, 2020
4.59M
Purchase
Mar 18
Form 4
34.90%
8.53M
$3.75
$5.62M
Nov 08, 2019
32.98M
Grant
Nov 07
Form 3
Nov 08, 2019
Showing 12 results